AN2 Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Menlo Park, CA
SEC filing record 1 source field available
Fiscal year end
31 December
AN2 Therapeutics, Inc. has filed 384 SEC EDGAR filings since 24 Sep 2021

SEC filing history

Showing 101-125 of 384 matching filings.

Per page
25
Current page
5
SCHEDULE 13G File 005-93617

SCHEDULE 13G filing

Filing date
04 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Jun 2025
Reporting date
02 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-93617

SCHEDULE 13D/A filing

Filing date
30 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
30 May 2025
Reporting date
28 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
29 May 2025
Reporting date
28 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 May 2025
Reporting date
22 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 May 2025
Reporting date
22 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 May 2025
Reporting date
22 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 May 2025
Reporting date
22 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 May 2025
Reporting date
22 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 May 2025
Reporting date
22 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 May 2025
Reporting date
22 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 May 2025
Reporting date
22 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D File 005-93617

SCHEDULE 13D filing

Filing date
07 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
11 Apr 2025
Reporting date
10 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
11 Apr 2025
Reporting date
10 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
11 Apr 2025
Reporting date
10 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
11 Apr 2025
Reporting date
10 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-41331

ARS

Filing date
11 Apr 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-41331

DEFA14A

Filing date
10 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .